You are here: Industry Insights > Central Nervous System

News List

Methylmercury Toxicity Found From Skin-Lightening Cream drugs
December 30, 2019
In a Notes from the Field report, published in the December issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report ...
SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System pharmafocusasia
January 11, 2019
SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced today that it signed a license and collaboration agreement with Denali Therapeutics....
Boehringer inks pact with Domain for GPCR neurology drugs fiercebiotech
January 02, 2019
French-Canadian biotech Domain Therapeutics has another big pharma partner, signing a deal with Germany’s Boehringer Ingelheim to develop new drugs for central nervous system (CNS) disorders....
Second time lucky? Alzheon tries for much-reduced IPO fiercebiotech
August 29, 2018
Alzheon is planning a phase 2b trial.
New research claims first response of nervous system tumour to CAR T therapy pharmafile
August 30, 2017
Researchers at a General Hospital in Massachusetts has claimed first-ever response of a nervous system tumour to CAR T cancer therapy.
Cerecor CEO retires after scoring Johnson & Johnson license deal fiercebiotech
August 16, 2017
J&J is paying $25 million upfront for rights to CERC-501.